Anticancer activities of phytoconstituents and their liposomal targeting strategies against tumor cells and the microenvironment

Adv Drug Deliv Rev. 2020:154-155:245-273. doi: 10.1016/j.addr.2020.05.006. Epub 2020 May 28.

Abstract

Various bioactive ingredients have been extracted from Chinese herbal medicines (CHMs) that affect tumor progression and metastasis. To further understand the mechanisms of CHMs in cancer therapy, this article summarizes the effects of five categories of CHMs and their active ingredients on tumor cells and the tumor microenvironment. Despite their treatment potential, the undesirable physicochemical properties (poor permeability, instability, high hydrophilicity or hydrophobicity, toxicity) and unwanted pharmacokinetic profiles (short half-life in blood and low bioavailability) restrict clinical studies of CHMs. Therefore, development of liposomes through relevant surface modifying techniques to achieve targeted CHM delivery for cancer cells, i.e., extracellular and intracellular targets and targets in tumor microenvironment or vasculature, have been reviewed. Current challenges of liposomal targeting of these phytoconstituents and future perspective of CHM applications are discussed to provide an informative reference for interested readers.

Keywords: Anti-tumor effect; Chinese herbal medicines; Liposomes; Targeting strategies; Tumor microenvironment.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Antineoplastic Agents, Phytogenic / administration & dosage*
  • Drugs, Chinese Herbal / administration & dosage*
  • Humans
  • Liposomes
  • Medicine, Chinese Traditional
  • Neoplasms / drug therapy*
  • Phytotherapy*
  • Tumor Microenvironment / drug effects

Substances

  • Antineoplastic Agents, Phytogenic
  • Drugs, Chinese Herbal
  • Liposomes